Impact of using stated instead of measured height upon screening spirometry

Joseph M. Parker, Thomas A Dillard, Yancy Y. Phillips

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This study examined the impact of using stated height instead of measured height on predicted normal values and clinical interpretation of screening spirometry in an outpatient referral population. In a prospective fashion, we evaluated 210 patients, 20 to 89 yr of age, referred for spirometry to our pulmonary function laboratory by obtaining both stated height (HT(s)) and measured height (HT(m)). The mean difference between stated and measured height progressively increased with age, from 0.80 cm (20 to 29 yr; p = 0.01) to 5.70 cm (80 to 89 yr; p < 0.001). For men and women, use of HT(s) instead of HT(m) produced a mean difference for all ages in computing predicted FEV1 and FVC values of 3.9 and 4.3%, respectively. This effect was more prominent in the older age groups (80 to 89 yr, n = 30); mean differences were 11.0% (211 ml) and 11.7% (303 ml), respectively. Use of HT(s) instead of HT(m) altered the detection of restriction by reduced FVC in 17 patients and the detection of obstruction by reduced FEV1/FVC ratio in four patients. Use of HT(s) altered the clinical assessment of severity by FEV1 in 15 of 108 (13.9%) obstructed patients and altered the assessment of severity by FVC in 11 of 32 (34.4%) restricted patients, with older patients more frequently affected than younger patients. We conclude that the use of stated height instead of measured height in the performance of screening spirometry can have significant impact on the calculation of predicted normal values. These discrepancies can potentially influence the clinical interpretation of screening spirometry, affecting the detection of abnormality and the assessment of severity of disease, particularly among older patients.

Original languageEnglish (US)
Pages (from-to)1705-1708
Number of pages4
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume150
Issue number6 I
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Spirometry
Reference Values
Outpatients
Referral and Consultation
Age Groups
Lung
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Impact of using stated instead of measured height upon screening spirometry. / Parker, Joseph M.; Dillard, Thomas A; Phillips, Yancy Y.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 150, No. 6 I, 01.01.1994, p. 1705-1708.

Research output: Contribution to journalArticle

Parker, Joseph M. ; Dillard, Thomas A ; Phillips, Yancy Y. / Impact of using stated instead of measured height upon screening spirometry. In: American Journal of Respiratory and Critical Care Medicine. 1994 ; Vol. 150, No. 6 I. pp. 1705-1708.
@article{2ae47ef454794b379cfecd85b166bb8a,
title = "Impact of using stated instead of measured height upon screening spirometry",
abstract = "This study examined the impact of using stated height instead of measured height on predicted normal values and clinical interpretation of screening spirometry in an outpatient referral population. In a prospective fashion, we evaluated 210 patients, 20 to 89 yr of age, referred for spirometry to our pulmonary function laboratory by obtaining both stated height (HT(s)) and measured height (HT(m)). The mean difference between stated and measured height progressively increased with age, from 0.80 cm (20 to 29 yr; p = 0.01) to 5.70 cm (80 to 89 yr; p < 0.001). For men and women, use of HT(s) instead of HT(m) produced a mean difference for all ages in computing predicted FEV1 and FVC values of 3.9 and 4.3{\%}, respectively. This effect was more prominent in the older age groups (80 to 89 yr, n = 30); mean differences were 11.0{\%} (211 ml) and 11.7{\%} (303 ml), respectively. Use of HT(s) instead of HT(m) altered the detection of restriction by reduced FVC in 17 patients and the detection of obstruction by reduced FEV1/FVC ratio in four patients. Use of HT(s) altered the clinical assessment of severity by FEV1 in 15 of 108 (13.9{\%}) obstructed patients and altered the assessment of severity by FVC in 11 of 32 (34.4{\%}) restricted patients, with older patients more frequently affected than younger patients. We conclude that the use of stated height instead of measured height in the performance of screening spirometry can have significant impact on the calculation of predicted normal values. These discrepancies can potentially influence the clinical interpretation of screening spirometry, affecting the detection of abnormality and the assessment of severity of disease, particularly among older patients.",
author = "Parker, {Joseph M.} and Dillard, {Thomas A} and Phillips, {Yancy Y.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1164/ajrccm.150.6.7952637",
language = "English (US)",
volume = "150",
pages = "1705--1708",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6 I",

}

TY - JOUR

T1 - Impact of using stated instead of measured height upon screening spirometry

AU - Parker, Joseph M.

AU - Dillard, Thomas A

AU - Phillips, Yancy Y.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - This study examined the impact of using stated height instead of measured height on predicted normal values and clinical interpretation of screening spirometry in an outpatient referral population. In a prospective fashion, we evaluated 210 patients, 20 to 89 yr of age, referred for spirometry to our pulmonary function laboratory by obtaining both stated height (HT(s)) and measured height (HT(m)). The mean difference between stated and measured height progressively increased with age, from 0.80 cm (20 to 29 yr; p = 0.01) to 5.70 cm (80 to 89 yr; p < 0.001). For men and women, use of HT(s) instead of HT(m) produced a mean difference for all ages in computing predicted FEV1 and FVC values of 3.9 and 4.3%, respectively. This effect was more prominent in the older age groups (80 to 89 yr, n = 30); mean differences were 11.0% (211 ml) and 11.7% (303 ml), respectively. Use of HT(s) instead of HT(m) altered the detection of restriction by reduced FVC in 17 patients and the detection of obstruction by reduced FEV1/FVC ratio in four patients. Use of HT(s) altered the clinical assessment of severity by FEV1 in 15 of 108 (13.9%) obstructed patients and altered the assessment of severity by FVC in 11 of 32 (34.4%) restricted patients, with older patients more frequently affected than younger patients. We conclude that the use of stated height instead of measured height in the performance of screening spirometry can have significant impact on the calculation of predicted normal values. These discrepancies can potentially influence the clinical interpretation of screening spirometry, affecting the detection of abnormality and the assessment of severity of disease, particularly among older patients.

AB - This study examined the impact of using stated height instead of measured height on predicted normal values and clinical interpretation of screening spirometry in an outpatient referral population. In a prospective fashion, we evaluated 210 patients, 20 to 89 yr of age, referred for spirometry to our pulmonary function laboratory by obtaining both stated height (HT(s)) and measured height (HT(m)). The mean difference between stated and measured height progressively increased with age, from 0.80 cm (20 to 29 yr; p = 0.01) to 5.70 cm (80 to 89 yr; p < 0.001). For men and women, use of HT(s) instead of HT(m) produced a mean difference for all ages in computing predicted FEV1 and FVC values of 3.9 and 4.3%, respectively. This effect was more prominent in the older age groups (80 to 89 yr, n = 30); mean differences were 11.0% (211 ml) and 11.7% (303 ml), respectively. Use of HT(s) instead of HT(m) altered the detection of restriction by reduced FVC in 17 patients and the detection of obstruction by reduced FEV1/FVC ratio in four patients. Use of HT(s) altered the clinical assessment of severity by FEV1 in 15 of 108 (13.9%) obstructed patients and altered the assessment of severity by FVC in 11 of 32 (34.4%) restricted patients, with older patients more frequently affected than younger patients. We conclude that the use of stated height instead of measured height in the performance of screening spirometry can have significant impact on the calculation of predicted normal values. These discrepancies can potentially influence the clinical interpretation of screening spirometry, affecting the detection of abnormality and the assessment of severity of disease, particularly among older patients.

UR - http://www.scopus.com/inward/record.url?scp=0027938919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027938919&partnerID=8YFLogxK

U2 - 10.1164/ajrccm.150.6.7952637

DO - 10.1164/ajrccm.150.6.7952637

M3 - Article

VL - 150

SP - 1705

EP - 1708

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6 I

ER -